Eczema Drug Shows Promising Phase 2 Results for Treatment of …
AJMC.com Managed Markets Network Dupilumab's effectiveness is due to the monoclonal antibody's ability to rapidly reduce inflammation. |
Eczema Drug Shows Promising Phase 2 Results for Treatment of …
AJMC.com Managed Markets Network Dupilumab's effectiveness is due to the monoclonal antibody's ability to rapidly reduce inflammation. |